Serologic testing indicated prior exposure to hepatitis A and hepatitis B, evidenced by reactive hepatitis A total antibody and elevated hepatitis B surface antibody (>500 IU/mL) with negative surface antigen and IgM - consistent with immunity from past infection or vaccination. The gene discussed is CD40LG; the disease is hepatitis B virus infection.